[177Lu]Lu-XT117

N/A

Report date: 2025/09/19 17:44:47

NME

Base Information

Drug Name[177Lu]Lu-XT117

Drug Alias Name[177Lu]Lu-XT117XTR-017XTR017

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionFibroblast activation protein alpha inhibitors

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBeijing Xiantong International Technology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A